CDC advisory panel delays vote on hepatitis B vaccine

A CDC advisory panel convened to discuss the potential alteration of the recommended birth dose of the hepatitis B vaccine for newborns, a move that could limit access for many low-income families. This decision follows pressure from officials associated with the Trump administration, raising concerns about the implications for public health.

Clinics in Mexico are providing psychedelic therapy options, including ibogaine treatment, particularly for U.S. Army veterans dealing with depression and PTSD. Health Secretary Robert F. Kennedy Jr. has expressed a willingness to explore these alternative therapies, despite warnings from experts about potential risks such as cardiac and neurological harm.

A mother is advocating for insurance coverage for her 12-year-old daughter, a competitive dancer diagnosed with scoliosis, whose surgery has been denied despite medical recommendations. This situation highlights the challenges families face in securing necessary medical treatments when insurance companies refuse coverage.

The CDC vaccine advisory group has postponed a planned vote on the hepatitis B vaccine for infants, originally scheduled for Thursday, to allow members additional time to review proposed changes to longstanding vaccination policies. This decision follows a contentious discussion among the advisers regarding the implications of altering the vaccination schedule for newborns.

The CDC's vaccine advisory panel has postponed a crucial vote on hepatitis B vaccines following a tumultuous meeting characterized by misinformation. This delay raises concerns about the decision-making process regarding public health vaccines.

A recent study suggests that a volcanic eruption around 1345 may have contributed to the arrival of the plague in Europe by cooling the climate and causing crop failures. This environmental disruption led to the transportation of grain by ships, which inadvertently carried plague-carrying fleas.

A federal vaccine advisory committee is set to discuss the recommendation for newborns to receive the hepatitis B vaccine, which is currently advised to be administered within 24 hours of birth. This meeting comes as Health Secretary Robert F. Kennedy Jr.'s committee may propose changes that contradict longstanding public health guidelines regarding this cancer-preventing vaccine.

The Centers for Disease Control and Prevention (CDC) is considering a significant change to its vaccination policy, potentially ending the routine administration of the hepatitis B vaccine to newborns within 24 hours of birth. This decision is expected to be voted on by a panel of advisers, reflecting a shift in the long-standing practice of vaccinating infants against this virus.